Literature DB >> 12461376

Limb salvage with tumor endoprostheses for malignant tumors of the knee.

W Plötz1, H Rechl, R Burgkart, C Messmer, R Schelter, E Hipp, R Gradinger.   

Abstract

Data of 64 consecutive patients with malignant tumors of the knee treated with tumor endoprostheses between 1976 and 1996 were reviewed. The study was retrospective before 1990 and prospective since then. Four patients were lost to followup and are not included in the study. The average age of the remaining 60 patients was 33.2 years (range, 9-72 years). Fifty patients had surgery for primary sarcoma and 10 patients had surgery for metastases of carcinoma. In the patients in the sarcoma group, the probability of 5 years survival was 72% and 10 years survival was 69%. The overall clinical score of 47 patients with a followup more than 9 months was 81% using the evaluation system of the International Society of Limb Salvage. Fifty-eight reoperations were done in 29 patients because of complications. Twenty reoperations were attributable to soft tissue complications, 34 reoperations were because of mechanical problems related to the prostheses, and four were because of local tumor recurrence. The probability of survival of the leg of the patient after 10 years was 95%. Despite a high rate of complications after limb salvage with endoprostheses, the final clinical outcome usually was good.

Entities:  

Mesh:

Year:  2002        PMID: 12461376     DOI: 10.1097/00003086-200212000-00027

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  35 in total

1.  CORR Insights®: What Are the Long-term Results of MUTARS® Modular Endoprostheses for Reconstruction of Tumor Resection of the Distal Femur and Proximal Tibia?

Authors:  Hannes A Rüdiger
Journal:  Clin Orthop Relat Res       Date:  2016-01-13       Impact factor: 4.176

2.  Early distal femoral endoprosthetic survival: cemented stems versus the Compress implant.

Authors:  A A Bhangu; M J Kramer; R J Grimer; R J O'Donnell
Journal:  Int Orthop       Date:  2006-09-16       Impact factor: 3.075

Review 3.  [Revision of tumour endoprostheses around the knee joint. Review and own results].

Authors:  R Windhager; A Leithner; M Hochegger
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

Review 4.  [Reconstruction of the extensor tendons in revision total knee arthroplasty and tumor surgery].

Authors:  L Gerdesmeyer; H Gollwitzer; P Diehl; R Burgkart; E Steinhauser
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

5.  [The modular MML revision system in knee revision and tumor arthroplasty].

Authors:  L Gerdesmeyer; A Töpfer; J Kircher; H Grundei; P Diehl
Journal:  Orthopade       Date:  2006-09       Impact factor: 1.087

6.  Perioperative infection rate in patients with osteosarcomas treated with resection and prosthetic reconstruction.

Authors:  Xin Li; Vincent M Moretti; Adedayo O Ashana; Richard D Lackman
Journal:  Clin Orthop Relat Res       Date:  2011-05-12       Impact factor: 4.176

Review 7.  [Management of complications in megaprostheses].

Authors:  J Hardes; H Ahrens; G Gosheger; M Nottrott; R Dieckmann; M-P Henrichs; A Streitbürger
Journal:  Unfallchirurg       Date:  2014-07       Impact factor: 1.000

8.  Compress periprosthetic fractures: interface stability and ease of revision.

Authors:  Wakenda K Tyler; John H Healey; Carol D Morris; Patrick J Boland; Richard J O'Donnell
Journal:  Clin Orthop Relat Res       Date:  2009-06-30       Impact factor: 4.176

9.  An aggressive chondroblastoma of the knee treated with resection arthrodesis and limb lengthening using the Ilizarov technique.

Authors:  Slavko Tomić; Aleksandar Lesić; Marko Bumbasirević; Jelena Sopta; Zoran Rakocević; Henry D Atkinson
Journal:  J Orthop Surg Res       Date:  2010-07-28       Impact factor: 2.359

10.  Compressive osseointegration of tibial implants in primary cancer reconstruction.

Authors:  Richard J O'Donnell
Journal:  Clin Orthop Relat Res       Date:  2009-08-04       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.